학술논문
Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial
Document Type
Article
Author
Africa, Hadn; Arendsen, Denis; Botes, Natasja; Cloete, Yolundi; De Kock, Marwou; Erasmus, Margaret; Jack, Lungisa; Kafaar, Fazlin; Kalepu, Xoliswa; Khomba, Nondumiso Gloria; Kruger, Sandra; Leopeng, Thelma; Makhethe, Lebohang; Mouton, Angelique; Mulenga, Humphrey; Musvosvi, Munyaradzi; Noble, Julia; Opperman, Fajwa; Reid, Tim; Rossouw, Susan; Schreuder, Constance; Smit, Erica; Steyn, Marcia; Tyambethu, Petrus; Van Rooyen, Elma; Veldsman, Ashley; Tameris, Michele ; Mearns, Helen ; Penn-Nicholson, Adam; Gregg, Yolande; Bilek, Nicole; Mabwe, Simbarashe; Geldenhuys, Hennie; Shenje, Justin; Luabeya, Angelique Kany Kany; Murillo, Ingrid; Doce, Juana; Aguilo, Nacho; Marinova, Dessislava; Puentes, Eugenia; Rodríguez, Esteban; Gonzalo-Asensio, Jesús; Fritzell, Bernard; Thole, Jelle; Martin, Carlos; Scriba, Thomas J; Hatherill, Mark
Source
In The Lancet Respiratory Medicine September 2019 7(9):757-770
Subject
Language
ISSN
2213-2600